Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
AstraZeneca
Queensland Health
Moodys
QuintilesIMS
Chubb
Harvard Business School
Express Scripts
Medtronic
US Army

Generated: August 18, 2017

DrugPatentWatch Database Preview

REPAGLINIDE AND METFORMIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Repaglinide And Metformin Hydrochloride, and what generic Repaglinide And Metformin Hydrochloride alternatives are available?

Repaglinide And Metformin Hydrochloride is a drug marketed by Lupin Ltd and is included in one NDA.

The generic ingredient in REPAGLINIDE AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; repaglinide. There are forty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the metformin hydrochloride; repaglinide profile page.

Summary for Tradename: REPAGLINIDE AND METFORMIN HYDROCHLORIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list105,694
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:REPAGLINIDE AND METFORMIN HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: REPAGLINIDE AND METFORMIN HYDROCHLORIDE

Ingredient-typeBiguanides
Drug ClassBiguanide
Glinide
Mechanism of ActionPotassium Channel Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
REPAGLINIDE AND METFORMIN HYDROCHLORIDE
metformin hydrochloride; repaglinide
TABLET;ORAL200624-001Jul 15, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
REPAGLINIDE AND METFORMIN HYDROCHLORIDE
metformin hydrochloride; repaglinide
TABLET;ORAL200624-002Jul 15, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Chubb
Express Scripts
Johnson and Johnson
Julphar
Dow
Teva
McKesson
Novartis
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot